Replies to post #227958 on Biotech Values

[DewDiligence]

SWAV acquires NVCN for $27.25 cash +CVR:

https://www.globenewswire.com/news-release/2023/01/17/2589887/0/en/Shockwave-Medical-Announces-Agreement-to-Acquire-Neovasc.html

Excluding the CVR, the buyout price is a 27% premium to Friday’s closing price. The nominal deal value (sans CVR) is $100M.